Home LiteratureArticle Details
PMID: 10449771 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro.

Rees W, Bender J, Teague TK, Kedl RM, Crawford F, Marrack P, Kappler J

Abstract

Multimeric peptide/class II MHC staining reagents were synthesized and shown to bind with appropriate specificity to T cell hybridomas. A small, expanded population of T cells detected with one of these reagents in peptide-immunized C57BL/10 mice persisted for several months. This population expanded further on secondary immunization. Equating the extent of binding of this reagent to T cell receptor affinity, we saw little correlation of immunizing peptide dose to T cell receptor affinity at the peak of the primary response. However, there was an inverse relation between peptide dose and the apparent receptor affinity of the T cells that were present several months after a primary response or after a secondary stimulation either in vivo or in vitro.

MeSH Terms
Animals CD4-Positive T-Lymphocytes/immunology Flow Cytometry Histocompatibility Antigens Class II/immunology Hyaluronan Receptors/immunology Hybridomas/immunology Immunization, Secondary Mice Mice, Inbred C57BL Receptors, Antigen, T-Cell/physiology
Chemicals
Histocompatibility Antigens Class II Hyaluronan Receptors Receptors, Antigen, T-Cell
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Rees W
Howard Hughes Medical Institute, Division of Basic Immunology, National Jewish Medical and Research Center, Denver, CO 80206, USA.
Bender J
Teague T K
Kedl R M
Crawford F
Marrack P
Kappler J
References (46)
46 references, click to expand
  1. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.
    Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12862-6 PMID: 7809136
  2. A kinetic basis for T cell receptor repertoire selection during an immune response.
    Immunity. 1999 Apr;10(4):485-92 PMID: 10229191
  3. Serial triggering of many T-cell receptors by a few peptide-MHC complexes.
    Nature. 1995 May 11;375(6527):148-51 PMID: 7753171
  4. Cell selection by antigen in the immune response.
    Adv Immunol. 1969;10:1-50 PMID: 4900673
  5. The frequency and activity of single helper T cells.
    J Immunol. 1974 Sep;113(3):830-4 PMID: 4607190
  6. Sequences of mouse immunoglobulin light chain genes before and after somatic changes.
    Cell. 1978 Dec;15(4):1133-44 PMID: 103630
  7. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.
    J Exp Med. 1981 May 1;153(5):1198-214 PMID: 6166712
  8. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication.
    J Immunol. 1981 Dec;127(6):2488-95 PMID: 6170707
  9. Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d and k.
    Eur J Immunol. 1982 Nov;12(11):909-14 PMID: 6185346
  10. Mutation drift and repertoire shift in the maturation of the immune response.
    Immunol Rev. 1987 Apr;96:23-41 PMID: 3298007
  11. Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors.
    J Immunol. 1989 Apr 15;142(8):2736-42 PMID: 2467936
  12. Two better cell lines for making hybridomas expressing specific T cell receptors.
    J Immunol. 1989 Sep 15;143(6):1822-5 PMID: 2778316
  13. Roles of alpha beta and gamma delta T cell subsets in viral immunity.
    Annu Rev Immunol. 1992;10:123-51 PMID: 1534240
  14. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.
    J Immunol. 1992 Aug 1;149(3):972-80 PMID: 1634779
  15. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli.
    Biotechnology (N Y). 1993 Oct;11(10):1138-43 PMID: 7764094
  16. Production of soluble MHC class II proteins with covalently bound single peptides.
    Nature. 1994 May 12;369(6476):151-4 PMID: 8177320
  17. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity.
    Science. 1994 Aug 12;265(5174):946-9 PMID: 8052850
  18. Prevalence and activation phenotype of Sendai virus-specific CD4+ T cells.
    Virology. 1995 Jun 20;210(1):179-85 PMID: 7540783
  19. Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-2lAb gene.
    J Immunol. 1995 Sep 15;155(6):2955-9 PMID: 7673713
  20. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.
    Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4102-7 PMID: 8633023
  21. On immunological memory.
    Annu Rev Immunol. 1996;14:333-67 PMID: 8717518
  22. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists.
    Immunity. 1996 Jul;5(1):53-61 PMID: 8758894
  23. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
    Int Immunol. 1996 May;8(5):641-9 PMID: 8671651
  24. Biophysical studies of T-cell receptors and their ligands.
    Curr Opin Immunol. 1996 Feb;8(1):93-100 PMID: 8729452
  25. Phenotypic analysis of antigen-specific T lymphocytes.
    Science. 1996 Oct 4;274(5284):94-6 PMID: 8810254
  26. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells.
    Science. 1996 Dec 20;274(5295):2094-7 PMID: 8953043
  27. Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2.
    J Immunol. 1996 Dec 15;157(12):5403-10 PMID: 8955188
  28. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition.
    Immunol Today. 1997 Jun;18(6):299-304 PMID: 9190117
  29. Affinity and kinetics of the interactions between an alphabeta T-cell receptor and its superantigen and class II-MHC/peptide ligands.
    Mol Immunol. 1997 Apr;34(6):493-503 PMID: 9307065
  30. Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease.
    J Virol. 1997 Dec;71(12):9672-8 PMID: 9371632
  31. Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization.
    Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13838-43 PMID: 9391114
  32. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection.
    Cell. 1998 Jan 23;92(2):173-82 PMID: 9458042
  33. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
    Immunity. 1998 Feb;8(2):177-87 PMID: 9491999
  34. Engineering protein for X-ray crystallography: the murine Major Histocompatibility Complex class II molecule I-Ad.
    Protein Sci. 1998 Feb;7(2):413-8 PMID: 9521118
  35. T cell positive selection by a high density, low affinity ligand.
    Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4522-6 PMID: 9539770
  36. The numbers game for virus-specific CD8+ T cells.
    Science. 1998 Apr 10;280(5361):227 PMID: 9565533
  37. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex.
    J Exp Med. 1998 May 4;187(9):1373-81 PMID: 9565630
  38. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.
    J Exp Med. 1998 May 4;187(9):1383-93 PMID: 9565631
  39. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.
    J Exp Med. 1998 May 4;187(9):1395-402 PMID: 9565632
  40. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen.
    Immunity. 1998 Jun;8(6):667-73 PMID: 9655480
  41. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.
    Immunity. 1998 Jun;8(6):675-82 PMID: 9655481
  42. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia.
    Immunity. 1998 Jun;8(6):683-91 PMID: 9655482
  43. Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus.
    J Immunol. 1998 Oct 1;161(7):3215-8 PMID: 9759834
  44. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
    J Immunol. 1999 Feb 15;162(4):2227-34 PMID: 9973498
  45. T cell affinity maturation by selective expansion during infection.
    J Exp Med. 1999 Feb 15;189(4):701-10 PMID: 9989985
  46. Cell surface expression of class II MHC proteins bound by a single peptide.
    J Immunol. 1995 Apr 15;154(8):3852-62 PMID: 7706725
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1999-08-17
Pages
9781-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC22287
Subset
IM
Grants
NIAID NIH HHS · R01 AI018785 · United States
NIAID NIH HHS · AI-17134 · United States
NIAID NIH HHS · AI-18785 · United States
NIAID NIH HHS · R01 AI017134 · United States
NIAID NIH HHS · R37 AI018785 · United States
NIAID NIH HHS · R56 AI017134 · United States
NIAID NIH HHS · AI-22295 · United States
NIAID NIH HHS · R56 AI018785 · United States
NIAID NIH HHS · P01 AI022295 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com